Citeline, Norstella complete $5B merger
Citeline and Norstella announced the completion of their $5 billion merger Tuesday morning.
The deal, first announced in late June, creates one of the world’s largest pharmaceutical intelligence solutions providers. The combined company has $5 billion and 1,600 employees.
Citeline will join four other brands, Evaluate, MMIT, Panalgo and The Dedham Group, as part of Norstella.
MMIT announces the winners of the seventh-annual specialty pharmacy Patient Choice Awards
May 9, 2022, Yardley, PA – Managed Markets Insight & Technology (MMIT)—the trusted go-to-market partner for overcoming barriers to patient access—has announced the winners of the seventh-annual Specialty Pharmacy Patient Choice Awards.
Each year, MMIT hosts the Patient Choice Awards to honor specialty pharmacies that provide best-in-class customer satisfaction and overall patient care within four categories: Payer/PBM, Hospital and Health System, Independent and Retail.
Four prominent pharmaceutical solutions providers launch Norstella to drive innovation and get patients access to life-saving therapies faster
May 3, 2022 – Creating a hub for rapid innovation, four prominent pharmaceutical solutions providers—Evaluate, MMIT, Panalgo and The Dedham Group—are thrilled to announce the launch of Norstella.
MMIT announces game-changing solution for life sciences companies
Feb. 17, 2022, Yardley, PA – Following the acquisition of healthcare analytics company Panalgo in September 2021, Managed Markets Insight & Technology (MMIT) has announced the launch of Patient Access Analytics
MMIT/Evaluate acquire Panalgo
The move will result in a disruptive, market-leading analytics platform that provides on-demand insights across dozens of normalized real-world evidence and market access data sets that support decision-making from pipeline to prescription September 28, 2021, Yardley, PA — Managed Markets Insight & Technology (MMIT) and Evaluate (a Welsh, Carson, Anderson & Stowe and Hg portfolio company)—which joined forces […]
MMIT and Evaluate join forces to offer an end-to-end view of the pharmaceutical market landscape
By combining their technology, data and expertise, MMIT and Evaluate will become a $1.6 billion global pharma commercial intelligence provider August 20, 2021, Yardley, PA — Managed Markets Insight & Technology (MMIT), LLC, the trusted go-to-market partner solely focused on solving the “what and why” of market access, has joined forces with London-based Evaluate, a leading provider of commercial […]
MMIT & The Dedham Group unite to smooth access to therapy
April 27, 2021, Yardley, PA – Managed Markets Insight & Technology, LLC. (MMIT), the trusted go-to-market partner solely focused on solving the “what and why” of market access—so that patients don’t face delays when trying to access lifesaving drugs—announced today that it will unite with The Dedham Group to smooth and enhance access to therapy. As […]